These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3435954)

  • 41. Synthesis and analgesic effect of N-substituted 5-arylidene-6-methyl-3-(4H)-pyridazinones.
    Rubat C; Coudert P; Couquelet J; Bastide P; Bastide J
    Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1558-61. PubMed ID: 3416373
    [No Abstract]   [Full Text] [Related]  

  • 42. [Synthesis and analgesic effect of 2-aryliminomethylquinolines].
    Hagen V; Dove B; Morgenstern E; Labes D; Göres E; Tomaschewski G; Geisler G; Franke C
    Pharmazie; 1983 Jul; 38(7):437-9. PubMed ID: 6634910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on peptides. CXXIII. Preparations of nine peptide fragments for the synthesis of human corticotropin releasing factor (hCRF).
    Fujii N; Nomizu M; Akaji K; Shimokura M; Katakura S; Yajima H
    Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4786-96. PubMed ID: 6335979
    [No Abstract]   [Full Text] [Related]  

  • 44. The mechanism by which cholecystokinin peptides excite their target cells. Review.
    Petersen OH
    Biosci Rep; 1984 Apr; 4(4):275-83. PubMed ID: 6329351
    [No Abstract]   [Full Text] [Related]  

  • 45. Structural characterization of beta-endorphin through the design, synthesis, and study of model peptides.
    Taylor JW; Miller RJ; Kaiser ET
    Mol Pharmacol; 1982 Nov; 22(3):657-66. PubMed ID: 6296658
    [No Abstract]   [Full Text] [Related]  

  • 46. Biological activity of the C-terminal octapeptide of cholecystokinin, of three of its analogues and of caerulein in the dog.
    Meyer FD; Gyr K; Kayasseh L; Jeker L; Wall M; Trzeciak A; Gillessen D
    Experientia; 1980 Apr; 36(4):434-6. PubMed ID: 7379916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The importance of the amino acid in position 27 of cholecystokinin in determining its biological activity on pancreatic acini.
    Gardner JD; Walker MD; Martinez J; Priestly GP; Natarajan S; Bodanszky M
    Biochim Biophys Acta; 1980 Jul; 630(3):323-9. PubMed ID: 6156709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus.
    Dodd J; Kelly JS
    Brain Res; 1981 Feb; 205(2):337-50. PubMed ID: 6162516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitory effect of cholecystokinin octapeptide on neurons in the nucleus tractus solitarius.
    Morin MP; de Marchi P; Champagnat J; Vanderhaeghen JJ; Rossier J; Denavit-Saubie M
    Brain Res; 1983 Apr; 265(2):333-8. PubMed ID: 6303513
    [No Abstract]   [Full Text] [Related]  

  • 50. COOH-terminal fragments of cholecystokinin. A new class of cholecystokinin receptor antagonists.
    Jensen RT; Jones SW; Gardner JD
    Biochim Biophys Acta; 1983 May; 757(2):250-8. PubMed ID: 6189522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opiate-like peptides. Part V. Aminoalkylamides of Met-enkephalin and [D-Ala]2-Met-enkephalin: synthesis and analgesic activity.
    Rolka K; Baran L; Przegaliński E; Kupryszewski G
    Pol J Pharmacol Pharm; 1984; 36(6):603-10. PubMed ID: 6535153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SYNTHESIS OF THE PEPTIDE FRAGMENT OF THE B-CHAIN OF INSULIN. VI. SYNTHESIS OF DERIVATIVES OF THE N-TERMINAL OCTAPEPTIDE.
    CHEN CC; HUANG WT; NIU CI
    Sci Sin; 1964 Aug; 13():1235-43. PubMed ID: 14206660
    [No Abstract]   [Full Text] [Related]  

  • 53. Modification of the C-terminal octapeptide of cholecystokinin with a high-specific-activity iodinated imidoester: preparation, characterization, and binding to isolated pancreatic acinar cells.
    Praissman M; Izzo RS; Berkowitz JM
    Anal Biochem; 1982 Mar; 121(1):190-8. PubMed ID: 6283943
    [No Abstract]   [Full Text] [Related]  

  • 54. Asymmetric alpha-substituted phenethylamines. VI. Synthesis and analgesic activity of optically pure (R)- and (S)-N-alkyl-1-cyclohexyl-2-phenylethylamines.
    Takahashi H; Chida Y; Yoshii T; Suzuki T; Yanaura S
    Chem Pharm Bull (Tokyo); 1986 May; 34(5):2071-7. PubMed ID: 3742651
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies on peptides. LXVII. Synthesis of the hexadecapeptide corresponding to position 1 through 16 of porcine cholecystokinin-pancreozymin (CCK-PZ).
    Mori Y; Koyama K; Kiso Y; Yajima H
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2788-93. PubMed ID: 1035145
    [No Abstract]   [Full Text] [Related]  

  • 56. Synthesis and biological activity of [MeTyr1,MeArg7,D-Leu8]-dynorphin A(1-9)-NHEt and [D-Cys2-Cys5,MeArg7,D-Leu8]-dynorphin A(1-9)-NH2.
    Yoshino H; Arakawa Y; Nakazawa T; Kaneko T; Matsunaga M; Araki S; Ikeda M; Tsuchiya Y; Yamatsu K; Tachibana S
    Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2274-6. PubMed ID: 1980641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Re-evaluation of glucagon1-6: the N-terminal hexapeptide of glucagon is not biologically active in the hepatic adenylate cyclase system.
    Pelton JT; Trivedi D; Hruby VJ
    Life Sci; 1983 Sep; 33(13):1307-14. PubMed ID: 6888179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Asymmetric alpha-substituted phenethylamines. IV. The synthesis and analgesic activity of optically pure (S) and (R)-1-cyclohexyl- and 1-cyclohexenyl-2-phenylethylamines.
    Takahashi H; Chida Y; Suzuki T; Onishi H; Yanaura S
    Chem Pharm Bull (Tokyo); 1984 Jul; 32(7):2714-23. PubMed ID: 6499084
    [No Abstract]   [Full Text] [Related]  

  • 59. Opiate-like peptides. Part IV. Kyotorphin and its analogues: synthesis and analgesic activity.
    Rolka K; Oslislok E; Krupa J; Kruszyński M; Baran L; Przegaliński E; Kupryszewski G
    Pol J Pharmacol Pharm; 1983; 35(6):473-80. PubMed ID: 6677896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and some biological properties of the hexapeptide analog of substance P with a C-terminal thioamide group.
    Kruszyński M; Kupryszewski G; Misterek K; Gumułka S
    Pol J Pharmacol Pharm; 1990; 42(5):483-90. PubMed ID: 1711685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.